Bafna Pharmaceuticals Limited — Others, 12-08-2025: Change in Management

Bafna Pharmaceuticals' Board has approved the re-appointment of two Independent Directors, Mrs. Ravichandran Chitra and Mr. Palamadai Krishnan Sundaresan, for a second five-year term, subject to shareholder approval. The Board also approved the re-appointment of Mr. Bafna Mahaveer Chand as Chief Executive Officer for a further five-year term. These decisions ensure continuity in the company's leadership and strategic direction. The re-appointed individuals bring significant experience across human resources, finance, and pharmaceutical operations, which strengthens the company's governance and operational expertise for long-term stability and growth.